SHAREHOLDER ALERT: Halper Sadeh LLP Investigates the Sale of These Companies; Are Shareholders Getting a Fair Deal? - FG, OPB, TTPH
Back to Newsroom
Mentioned in this Article

SHAREHOLDER ALERT: Halper Sadeh LLP Investigates the Sale of These Companies; Are Shareholders Getting a Fair Deal? - FG, OPB, TTPH

Tuesday, April 21, 2020 1:00 PM
Share this article now
Topic:
Class Action,Lawsuits

NEW YORK, NY / ACCESSWIRE / April 21, 2020 / Halper Sadeh LLP, a global investor rights law firm, continues to investigate whether the following proposed mergers are fair to shareholders. Halper Sadeh LLP may seek increased consideration, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders:

 

FGL Holdings (NYSE:FG)

The investigation concerns whether FGL Holdings and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders in connection with the proposed sale of FGL Holdings to Fidelity National Financial, Inc. If you are an FGL Holdings shareholder and would like to learn more about your legal rights and options, please visit: https://halpersadeh.com/actions/fgl-holdings-fg-stock-merger-fidelity-national/.

Opus Bank (NASDAQ:OPB)

The investigation concerns whether Opus Bank and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders in connection with the proposed sale of Opus Bank to Pacific Premier Bancorp, Inc. If you are an Opus Bank shareholder and would like to learn more about your legal rights and options, please visit: https://halpersadeh.com/actions/opus-bank-opb-stock-merger-pacific-premier/.

Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH)

The investigation concerns whether Tetraphase and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders in connection with the proposed sale of Tetraphase to AcelRx Pharmaceuticals, Inc. for 0.6303 shares of AcelRx for each share of Tetraphase. If you are a Tetraphase shareholder and would like to learn more about your legal rights and options, please visit: https://halpersadeh.com/actions/tetraphase-pharmaceuticals-inc-ttph-stock-merger-acelrx/.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email [email protected] or [email protected].

Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

CONTACT: 

Halper Sadeh LLP
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
[email protected]
[email protected]
https://www.halpersadeh.com

SOURCE:  Halper Sadeh LLP     

Halper Sadeh LLP
Back to Newsroom
Copyright 2021 © ACCESSWIRE. All rights reserved. Privacy Policy  |  Terms and Conditions
Drop us a line: